Literature DB >> 24189336

Combination of robot-assisted and conventional body-weight-supported treadmill training improves gait in persons with multiple sclerosis: a pilot study.

Jennifer Ruiz1, Michele P Labas, Elizabeth W Triche, Albert C Lo.   

Abstract

BACKGROUND AND
PURPOSE: The majority of persons with multiple sclerosis (MS) experience problems with gait, which they characterize as highly disabling impairments that adversely impact their quality of life. Thus, it is crucial to develop effective therapies to improve mobility for these individuals. The purpose of this study was to determine whether combination gait training, using robot-assisted treadmill training followed by conventional body-weight-supported treadmill training within the same session, improved gait and balance in individuals with MS.
METHODS: This study tested combination gait training in 7 persons with MS. The participants were randomized into the immediate therapy group (IT group) or the delayed therapy group (DT group). In phase I of the trial, the IT group received treatment while the DT group served as a concurrent comparison group. In phase II of the trial, the DT group received treatment identical to the treatment received by the IT group in phase I. Outcome measures included the 6-Minute Walk Test (6MWT), the Timed 25-Foot Walk Test, velocity, cadence, and the Functional Reach Test (FRT). Nonparametric statistical techniques were used for analysis.
RESULTS: Combination gait training resulted in significantly greater improvements in the 6MWT for the IT group (median change = +59 m) compared with Phase I DT group (median change = -8 m) (P = 0.08) and FRT (median change = +3.3 cm in IT vs -0.8 cm in the DT group phase I; P = 0.03). Significant overall pre-post improvements following combination gait training were found in 6MWT (+32 m; P = 0.02) and FRT (+3.3 cm; P = 0.06) for IT and Phase II DT groups combined.
CONCLUSIONS: Combination of robot with body-weight-supported treadmill training gait training is feasible and improved 6MWT and FRT distances in persons with MS.Video Abstract available (see Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A62) for more insights from the authors.

Entities:  

Mesh:

Year:  2013        PMID: 24189336     DOI: 10.1097/NPT.0000000000000018

Source DB:  PubMed          Journal:  J Neurol Phys Ther        ISSN: 1557-0576            Impact factor:   3.649


  7 in total

Review 1.  Settings matter: a scoping review on parameters in robot-assisted gait therapy identifies the importance of reporting standards.

Authors:  Florian van Dellen; Rob Labruyère
Journal:  J Neuroeng Rehabil       Date:  2022-04-22       Impact factor: 5.208

2.  Effects of Robot-Assisted Gait Training with Body Weight Support on Gait and Balance in Stroke Patients.

Authors:  Wonho Choi
Journal:  Int J Environ Res Public Health       Date:  2022-05-10       Impact factor: 4.614

3.  Critical Appraisal of Evidence for Improving Gait Speed in People with Multiple Sclerosis: Dalfampridine Versus Gait Training.

Authors:  Prudence Plummer
Journal:  Int J MS Care       Date:  2016 May-Jun

4.  The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial.

Authors:  Sofia Straudi; Fabio Manfredini; Nicola Lamberti; Paolo Zamboni; Francesco Bernardi; Giovanna Marchetti; Paolo Pinton; Massimo Bonora; Paola Secchiero; Veronica Tisato; Stefano Volpato; Nino Basaglia
Journal:  Trials       Date:  2017-02-27       Impact factor: 2.279

5.  Evaluation of the Keeogo exoskeleton for assisting ambulatory activities in people with multiple sclerosis: an open-label, randomized, cross-over trial.

Authors:  Chris A McGibbon; Andrew Sexton; Arun Jayaraman; Susan Deems-Dluhy; Pearl Gryfe; Alison Novak; Tilak Dutta; Eric Fabara; Catherine Adans-Dester; Paolo Bonato
Journal:  J Neuroeng Rehabil       Date:  2018-12-12       Impact factor: 4.262

6.  Over-ground walking or robot-assisted gait training in people with .multiple sclerosis: does the effect depend on baseline walking speed and disease related disabilities? A systematic review and meta-regression.

Authors:  Martin Sattelmayer; Odile Chevalley; Ruedi Steuri; Roger Hilfiker
Journal:  BMC Neurol       Date:  2019-05-08       Impact factor: 2.474

7.  Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot Study.

Authors:  Prudence Plummer; Silva Markovic-Plese; Barbara Giesser
Journal:  Front Rehabil Sci       Date:  2022-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.